Dr. Prasanth Manohar, Ph.D., – Page 45 – PHAGElogist

FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections

21 Mar 202021 Mar 2020

--Three Clinical Sites to Enroll Patients with Recurrent and Complicated Urinary Tract Infections-- GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response…

Armata Receives Up to $5M From CF Foundation to Develop Phage Therapy AP-PA02

The Cystic Fibrosis Foundation has awarded up to $5 million to Armata Pharmaceuticals to advance its potential treatment AP-PA02 — a phage therapy against multidrug-resistant Pseudomonas aeruginosa infections in cystic…

How phage therapy can help recover from SARS-CoV-2 secondary infections?

Source: © Shutterstock The world is going through one of the scariest pandemic of all time or at least the biggest of this generation. COVID-19 is caused by corona virus…

ZJE Post-doctoral researcher “Prasanth Manohar” awarded Young Scientist and only one from China

16 Mar 202021 Mar 2020

..Dr. Prasanth Manohar is working as a post-doctor in Dr Sebastian Leptihn’s lab in ZJE. He completed his Ph.D in Vellore Institute of Technology (VIT), Vellore, India, during which he…

YOUNG SCIENTIST- ‘ECCMID 30 under 30’

16 Mar 202021 Mar 2020

For the 30th edition of ECCMID, we would like to highlight 30 outstanding young scientists 30 years of age or younger. https://www.eccmid.org/scientific_programme/30_under_30/ https://www.escmid.org/fileadmin/src/media/PDFs/FinalProgramme30under30_web-2.pdf Dr. Prasanth Manohar is one of the…

Safety of phage therapy in patients

Researchers are looking into the potential of phage therapy to combat antibiotic resistance, with recent work suggesting there are no adverse reactions when given to patients with blood infections. New…

Bacteriophage Market

The global bacteriophage market was valued at US$ 567.9 million in 2017 and increased to CAGR by 3.9 per cent from 2018 to 2026. Market InsightsBacteriophages or phages have recently…

Controlled Phage Therapy

A growing concern in health care, antibiotic resistance weakens our ability to treat common infectious diseases. With antibiotics becoming less effective, researchers are looking into possible alternative treatment methods, including…

Mycobacteriophage ‘Is it a solution’?

6 Feb 202021 Mar 2020

The resurgence of tuberculosis and emergence of drug resistant disease has stimulated fresh research into mycobacteriophage. Studies are currently underway to develop phage-based tools for therapeutic and diagnostic use. Our…

Phage Therapy May Combine Efficacy and Convenience

Bringing to bear decades of experience as a researcher of phage biology, Carl R. Merril, MD, is working to realize the therapeutic promise of phages, the viruses that infect bacteria.…